-
1.
FDA Approves Genentech’s Vabysmo Prefilled Syringe for Three Leading Causes of Vision Loss
-
(Press Releases)
-
Genentech, a member of the Roche Group announced the U.S. Food and Drug Administration (FDA) has approved the Vabysmo® (faricimab-svoa) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment ...
-
2.
Fresenius Introduces Denosumab Biosimilars, Growing Its U.S. Portfolio
-
(Press Releases)
-
... biosimilars are approved by the FDA for all indications of the reference products, Prolia® (denosumab) and Xgeva® (denosumab), respectively. Conexxence is available in a 60 mg/mL single-use prefilled ...
-
3.
Gore Introduces 0.5 mL Silicone-Free GORE® IMPROJECT® Plunger for Ophthalmic Pre-Filled Syringes
-
(Innovations)
-
... The new offering is specially designed for prefilled syringes used in various applications, including ophthalmic intravitreal injections, and complements the GORE IMPROJECT 1 mLL plunger which Gore launched ...
-
4.
The next evolution of the V-OVS® syringe closure system is introduced by Vetter
-
(Press Releases)
-
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure system. ...
-
5.
Credence MedSystems achieves a significant milestone in scaling manufacturing capabilities
-
(Press Releases)
-
Credence MedSystems, an innovator of drug delivery systems that solve unmet market needs for the pharmaceutical industry, announced that it has successfully completed Factory Acceptance Testing (FAT) for ...
-
6.
IDACIO® (adalimumab-aacf) Now Available in the United States
-
(Press Releases)
-
... indications of the reference product.
Humira® (adalimumab). IDACIO® is available in a self-administered prefilled syringe and a self-administered pre-filled pen (autoinjector). “We are thrilled to ...
